Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001034629 | SCV000642207 | uncertain significance | Familial focal epilepsy with variable foci | 2019-09-30 | criteria provided, single submitter | clinical testing | This sequence change replaces asparagine with serine at codon 323 of the DEPDC5 protein (p.Asn323Ser). The asparagine residue is highly conserved and there is a small physicochemical difference between asparagine and serine. This variant is present in population databases (rs201776005, ExAC 0.03%), and has an allele count higher than expected for a pathogenic variant (PMID: 28166811). This variant has not been reported in the literature in individuals with DEPDC5-related disease. Algorithms developed to predict the effect of missense changes on protein structure and function do not agree on the potential impact of this missense change (SIFT: "Deleterious"; Align-GVGD: "Class C15"). In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Ambry Genetics | RCV000718495 | SCV000849359 | uncertain significance | Seizures | 2017-04-14 | criteria provided, single submitter | clinical testing | Insufficient evidence;In silico models in agreement (deleterious) and/or completely conserved position in appropriate species |
Fulgent Genetics, |
RCV000554818 | SCV000896957 | uncertain significance | Epilepsy, familial focal, with variable foci 1 | 2018-10-31 | criteria provided, single submitter | clinical testing |